PAS
MURA

Point72 Asia (Singapore)’s Mural Oncology MURA Stock Holding History

Point72 Asia (Singapore)’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,282
Closed -$39.5K – 1090
2024
Q4 		$39.5K Sell
12,282
-292
-2% -$1.03K 0.01% 547
2024
Q3 		$39.4K Sell
12,574
-14,068
-53% -$45.8K 0.01% 729
2024
Q2 		$83.7K Buy
+26,642
New +$98.2K 0.02% 533

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asia (Singapore)'s MURA Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 12,282 shares — an estimated $39.5K sold.

Point72 Asia (Singapore) first reported a position in MURA in Q2 2024 and held it in 3 quarters. The position peaked at $83.7K in Q2 2024. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 12,282 Mural Oncology shares in Q1 2025, an estimated $39.5K.
  • Point72 Asia (Singapore) first reported a position in Mural Oncology in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Mural Oncology position peaked at $83.7K in Q2 2024.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.